Business Information
The group's principal activity is the provision of clinical research and development services on a global basis to the pharmaceutical and biotechnology industries. The group specializes in the management, execution and analysis of complex, multinational clinical trials in most major therapeutic areas. Its operations are located in Ireland, the United Kingdom, United States, Germany, Australia, Argentina, France, Japan, Israel, Singapore, Canada, Sweden, the Netherlands, Latvia, South Africa and India. During fiscal 2003, the group acquired Barton & Polansky Associates Inc, Managed Clinical Solutions Inc, Medeval Group Ltd and Globomax Llc.
|
|
Name |
Title
|
Email
|
| John Climax | Exec. Chmn. | N/A | | Alan Morgan | Pres. - Icon Clinical Research, Europe | N/A | | Bill Taaffe | Pres. - Corporate Development | N/A | | Dan Weng | Pres. - Icon Clinical Research, ROW | N/A | | Robert Scott-Edwards | Pres. - Icon Central Laboratories | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 469,583 | 13,545 | | 2006 | 649,826 | 38,304 | | 2005 | 275,586 | 7,418
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
